H40.63 类别:需要更具体的编码 Glaucoma secondary to drugs, bilateral
ICD-10-CM H40.63 identifies “Glaucoma secondary to drugs, bilateral” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 7: Diseases of the eye and adnexa
编码说明
无额外说明。
上级编码说明
H40.6 · Glaucoma secondary to drugs
Use additional code1
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Seventh character1
One of the following 7th characters is to be assigned to each code in subcategory H40.6 to designate the stage of glaucoma
0 — stage unspecified
1 — mild stage
2 — moderate stage
3 — severe stage
4 — indeterminate stage
章节 7 · Diseases of the eye and adnexa (H00-H59)
Excludes 211
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury (trauma) of eye and orbit (S05.-)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- syphilis related eye disorders (A50.01, A50.3-, A51.43, A52.71)
Note1
Use an external cause code following the code for the eye condition, if applicable, to identify the cause of the eye condition
H40 · Glaucoma
更具体的编码
H40.63X0Glaucoma secondary to drugs, bilateral, stage unspecified可计费的具体编码H40.63X1Glaucoma secondary to drugs, bilateral, mild stage可计费的具体编码H40.63X2Glaucoma secondary to drugs, bilateral, moderate stage可计费的具体编码H40.63X3Glaucoma secondary to drugs, bilateral, severe stage可计费的具体编码H40.63X4Glaucoma secondary to drugs, bilateral, indeterminate stage可计费的具体编码官方索引引用
历史
编码历史
自首次收录以来无变更记录
生效日期
- 首次收录
Glaucoma secondary to drugs, bilateral
类别 — 请选择更具体的编码
CDC/NCHS · FY2016所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。